Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBTC
3751
DELISTED
Enterprise Bancorp
EBTC
| $220K | ﹤0.01% |
+7,004
| New | +$220K |
|
3752
Backblaze
BLZE
$539M
| $219K | ﹤0.01% |
+43,442
| New | +$219K |
|
3753
Crawford & Co Class B
CRD.B
$493M
| $219K | ﹤0.01% |
28,514
+9,047
| +46% | +$69.5K |
|
3754
TaskUs
TASK
$1.58B
| $217K | ﹤0.01% |
15,000
-127,567
| -89% | -$1.85M |
|
3755
Tyra Biosciences
TYRA
$659M
| $217K | ﹤0.01% |
+13,475
| New | +$217K |
|
|
FFNW
3756
DELISTED
First Financial Northwest, Inc
FFNW
| $217K | ﹤0.01% |
17,007
+5,903
| +53% | +$75.3K |
|
3757
Q32 Bio
QTTB
$22.7M
| $216K | ﹤0.01% |
11,649
-1,740
| -13% | -$32.3K |
|
3758
Cushman & Wakefield
CWK
$3.85B
| $213K | ﹤0.01% |
20,220
-29,218
| -59% | -$308K |
|
|
GDEV
3759
DELISTED
Nexters Inc. Ordinary Shares
GDEV
| $213K | ﹤0.01% |
31,116
-15,403
| -33% | -$105K |
|
3760
AstraZeneca
AZN
$240B
| $212K | ﹤0.01% |
3,056
-628,006
| -100% | -$43.6M |
|
3761
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$16B
| $211K | ﹤0.01% |
4,416
-87,086
| -95% | -$4.16M |
|
|
SRT
3762
DELISTED
Startek Inc.
SRT
| $210K | ﹤0.01% |
50,905
-31,794
| -38% | -$131K |
|
3763
Alto Ingredients
ALTO
$91.3M
| $209K | ﹤0.01% |
139,262
-615,137
| -82% | -$923K |
|
|
BGB
3764
Blackstone Strategic Credit 2027 Term Fund
BGB
$553M
| $209K | ﹤0.01% |
+19,611
| New | +$209K |
|
|
PTN
3765
DELISTED
Palatin Technologies
PTN
| $209K | ﹤0.01% |
75,997
+30,010
| +65% | +$82.5K |
|
3766
SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.87B
| $209K | ﹤0.01% |
8,425
-967,814
| -99% | -$24M |
|
|
SYRS
3767
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $209K | ﹤0.01% |
78,336
-13,137
| -14% | -$35K |
|
3768
Cogent Biosciences
COGT
$1.75B
| $208K | ﹤0.01% |
19,242
-180,940
| -90% | -$1.96M |
|
3769
Sprott Physical Gold
PHYS
$13.2B
| $207K | ﹤0.01% |
+13,400
| New | +$207K |
|
3770
TriplePoint Venture Growth BDC
TPVG
$251M
| $206K | ﹤0.01% |
17,068
-133,778
| -89% | -$1.61M |
|
3771
Cognyte Software
CGNT
$609M
| $205K | ﹤0.01% |
60,610
-341,563
| -85% | -$1.16M |
|
|
ICD
3772
DELISTED
Independence Contract Drilling, Inc.
ICD
| $205K | ﹤0.01% |
62,843
-109,108
| -63% | -$356K |
|
3773
Orion Group Holdings
ORN
$319M
| $204K | ﹤0.01% |
78,603
-29,055
| -27% | -$75.4K |
|
3774
STAAR Surgical
STAA
$1.35B
| $204K | ﹤0.01% |
3,186
-441,580
| -99% | -$28.3M |
|
3775
SPDR S&P Pharmaceuticals ETF
XPH
$168M
| $204K | ﹤0.01% |
4,968
-23,758
| -83% | -$976K |
|